New drugs for liver cancer treatment in China include atilizumab, bevacizumab, sindilizumab, donafenib, lenvatinib, regorafenib, apatinib, karelizumab, tirilizumab and so on. Liver cancer is a kind of malignant tumor, and China is a big country for liver cancer. Liver cancer patients who are not suitable for surgery or have distant metastasis can take systematic treatment such as drug therapy and radiation therapy. New drugs for liver cancer treatment in China include first-line drugs and second-line drugs. First-line drugs such as atilizumab, sindilizumab, doxorubicinib, lenvatinib and so on. Second-line drugs such as regorafenib, apatinib, karelizumab, tirilizumab. In recent years, some traditional Chinese medicines have also been used as adjuvant treatment after surgical resection of liver cancer, such as Sophora Ear Granules. It should be noted that the above drugs belong to prescription drugs, which should be purchased and used with a physician’s prescription.